Latest Capital Raise News

NexGen Energy Ltd. has launched a significant dual equity financing, successfully upsizing its Australian offering and targeting combined proceeds exceeding C$1 billion. This move underscores the company's strategic capital expansion across North American and Australian markets.

Lake Resources N.L. has launched a pro-rata bonus loyalty options offer to eligible shareholders, granting one option per ten shares held, exercisable at A$0.05 over three years. This move aims to reward shareholder support and potentially raise capital for advancing its Kachi lithium project in Argentina.

Ardiden Ltd’s trading suspension has been lifted following its announcement of a significant gold acquisition and a capital raising initiative, signaling a pivotal moment for the company’s growth strategy.

Invion Limited has secured $0.8 million through convertible notes to repay its Lind Global Fund II LP facility and support working capital, positioning itself for potential global licensing deals of its Photosoft technology.

Dreadnought Resources has successfully raised $18 million through a placement to accelerate its gold exploration efforts in Western Australia's Yilgarn region, with additional director participation pending shareholder approval.

Hiremii Group has successfully raised $650,000 through an oversubscribed placement, underscoring strong investor confidence as it pushes forward with commercialising its AI-driven recruitment platform.

DeSoto Resources has raised A$14 million in a strongly supported placement to fund its maiden drilling program in Guinea’s prolific Siguiri Basin, backed by a notable cornerstone investor and institutional interest.

Pacgold Limited’s trading suspension has been lifted following its announcement of a capital raising, signaling renewed market activity for the gold explorer.

Pacgold Limited has raised $13 million through a two-tranche placement to acquire and restart the White Dam Gold Project, aiming for near-term production and exploration growth.

Buru Energy secured key government approvals and identified a promising new gas prospect beneath its Rafael field, while raising $4.4 million to fund development activities. The company is gearing up for a Final Investment Decision in 3Q 2026, aiming for first material cash flow by 2028.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Arafura Rare Earths has successfully raised $9.83 million through an upsized Share Purchase Plan, well above its $5 million target, boosting total capital raised this year to nearly $90 million.